REGISTER
MedJ at JSCO 2025 with Dr. Elizabeth A. Mittendorf
MedJ at JSCO 2025 with Dr. Elizabeth A. Mittendorf is presented here as a key issue in JSCO. It pulls together the main findings on JSCO, ASCO, USA and shows what they may mean for diagnosis, monitoring, prevention, or treatment.

Elizabeth A. Mittendorf, ASCO President-Elect 2026-2027, Dana-Farber Cancer Institute, USA

Exclusive JSCO Interview: Emphasizing the Vital Collaboration Between JSCO and ASCO, and Envisioning a New Chapter in Sino-US Oncology Academic Exchange.

0
0
Loading